JAMA at CCR, Insulin Cost Caps for Medicare Beneficiaries, Mazdutide in Obesity and Orforglipron in Diabetes, and more
From JAMA Editors' Summary · · 21 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, Linda Brubaker, MD, Deputy Editor, and Christopher W. Seymour, MD, MSc, Associate Editor of JAMA, the Journal of the American Medical Association, for articles published from June 6-12, 2026. Related Content:
- Audio Highlights